Go to Healthcare Professionals Site
Customer Contact Center:
1-888-PLMZYME (756-9963)

Indication and Usage

Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics.

In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.

Important Safety Information

  • Pulmozyme should not be used in patients who are allergic to any of its ingredients. Pulmozyme should be used along with standard therapies for cystic fibrosis.
  • When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose.
  • These side effects are usually mild and short-lived.

For further information, please see the Pulmozyme full Prescribing Information. If you have questions, please discuss them with your CF healthcare team.

Pulmozyme Access Solutions

Financial Support

Financial Support

Visit CF Living
This online community is a place for CF patients and caregivers to get advice, share stories and learn about others fighting this disease.

Pulmozyme® Access Solutions® is here to help you access your medicines. We offer coverage and reimbursement support, patient assistance, and informational resources for both healthcare providers and their patients.

Pulmozyme Access Solutions Service Offerings
    • Help with benefits and coverage issues
      • Benefits investigation
      • Prior authorization
      • Recertification
    • Help with reimbursement issues
      • Denials and appeals
      • Billing and coding information
    • Genentech® Access to Care Foundation (GATCF) support for qualifying uninsured and rendered uninsured patients
    • Referrals to co-pay foundations for co-pay assistance
    • Pulmozyme Co-pay Card
    • CF Living
    • StarteRx Program
    • My Patient Solutions, our online patient management tool
    • Communication assistance services
      • Translation services
      • Telephone to telephone typewriter (TTY) services
    • Product spoilage and replacement information
    • Medicare/Medicaid search tool
    • Glossary of access and reimbursement terms

At Pulmozyme Access Solutions, we're here to help find a way for you to get the medicine your doctor has prescribed, even if you have no insurance. When you or your doctor's office call Pulmozyme Access Solutions, you will be connected with one of our experts, whose sole job is to make sure that you get the coverage or reimbursement help you need.

We work hard to make information you need about coverage and reimbursement easily available 24 hours a day. You can reach us: